United States v. Fairnot

District Court, District of Columbia·Decided July 27, 2026·No. Criminal No. 2023-0024·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

UNITED STATES OF AMERICA

v. Criminal Action No. 23-24 (JEB)

JERMAINE FAIRNOT,

Defendant.

MEMORANDUM OPINION

Awaiting retrial on an eight-count gun-and-drug indictment, Defendant Jermaine Fairnot

moves to dismiss the case against him on two grounds. First, he contends that chain-of-custody

issues and weight discrepancies concerning the phencyclidine recovered from his car — which

was introduced into evidence at his first trial — render that PCP evidence inadmissible. Second,

he maintains that the Government failed to preserve video surveillance footage from a nearby

Metropolitan Police Department crime camera, in violation of Federal Rule of Criminal

Procedure 16(a). Because neither argument has merit nor warrants dismissal, the Court will deny

the Motion.

I. Background

On December 18, 2025, Fairnot was charged via superseding indictment with eight

counts, all relating to his alleged possession of firearms and distribution-quantity drugs in two

incidents three weeks apart. See ECF No. 113 (Superseding Indict.). This case was first tried

beginning on January 13, 2026. Testimony at the four-day trial offered the following facts about

the first incident, which is the subject of the Motion:

On the evening of October 14, 2022, officers patrolling the area around King Greenleaf

Recreation Center seized, from Fairnot’s car, a handgun, a plastic apple-juice bottle containing

1 PCP, and 56 glass vials used to package PCP. See ECF No. 146 (Jan. 13 Tr.) at 108:16–19;

109:18–22, 142:3–145:4, 147:5–150:9. All evidence was transported that night to the MPD First

District station, where it was logged as received three days later. Id. at 159:21–25; see ECF No.

145-1, Exh. 1 (PCP Custody Log) at ECF p. 1. At the station, the PCP was placed on the drug

book, see Jan. 13 Tr. at 160:2–9, and, according to MPD Detective Brian McCarthy, transferred

by staff from the apple-juice bottle into glass vials. See ECF No. 147 (Jan. 15 Tr.) at 52:9–13;

102:23–103:5. Officers weighed the vials, reported their weight, and shipped the PCP to the

Drug Enforcement Administration for testing on October 25. Id. at 52:9–53:10; see PCP

Custody Log at ECF p. 1.

DEA Senior Forensic Chemist Erin Lloyd testified that she received and tested the PCP.

See ECF No. 148 (Jan. 20 Tr.) at 106:1–19. On cross-examination, Lloyd noted a discrepancy

between the gross weight (combined weight of packaging and contents) that she recorded and

that reported by the officers at the First District. Id. at 114:9–18. She explained, however, that

officers commonly, if inadvertently, report the net weight (weight of contents alone) of the

evidence instead of the gross weight, and that this explanation was “consistent” with the

discrepancy at hand given the closeness of the officers’ purported gross figure to her net figure.

Id. at 115:3–10.

As to the surveillance video, McCarthy testified that law enforcement obtained (1) video

footage from the Recreation Center capturing the nearly two hours up until officers discovered

the handgun and drugs in the vehicle and (2) video footage for the same time period from an

MPD crime camera on the opposite side of the parking lot from where the vehicle was parked.

See Jan. 13 Tr. at 197:5–12. The footage shows Fairnot driving the vehicle to the Recreation

2 Center, parking it there, and going in and out of that car over the span of the two hours. See Jan.

15 Tr. at 18:16–44:11.

On cross-examination, McCarthy testified that he did not request footage that would have

captured Fairnot’s vehicle leaving the lot after law enforcement seized the gun and drugs. See

Jan. 15 Tr. at 103:12–23. He explained that this was because he did not know “what the time

period [was]” for video that would have captured the vehicle’s departure. Id. at 104:1–4.

At the conclusion of the trial, the jury was unable to reach a verdict on any of the counts

of the superseding indictment; as a result, a mistrial was declared. With the retrial scheduled to

begin this week, Fairnot now moves to dismiss the case. See ECF No. 143 (MTD).

II. Legal Standard

A defendant may move prior to trial to dismiss an indictment. One basis for such a

motion is a defect in the process of “discovery under Rule 16.” Fed. R. Crim P. 12(b)(3)(E).

“Because a court’s use of its supervisory power to dismiss an indictment directly encroaches

upon the fundamental role of the grand jury, dismissal is granted only in unusual circumstances.”

United States v. Ballestas, 795 F.3d 138, 148 (D.C. Cir. 2015) (cleaned up).

III. Analysis

In seeking dismissal, Fairnot raises two separate arguments, which the Court addresses in

turn.

A. Chain of Custody

He first asserts that an amalgam of issues relating to the chain of custody renders the

recovered PCP inadmissible as evidence. As an initial matter, Fairnot never explains why the

inadmissibility of some drug evidence would warrant dismissal of the entire indictment, which

also includes gun charges, at this stage. Nor could he, as it is well established that the proper

3 remedy for inadmissible evidence is its exclusion, not dismissal of the case altogether. See

United States v. Blue, 384 U.S. 251, 255 & n.3 (1966) (holding that proper remedy for

inadmissible evidence is suppression at trial).

In any event, the issues Fairnot raises do not even counsel against admissibility of the

PCP. Because he does not clearly delineate his various contentions, it is difficult to discern the

precise contours of his arguments on that front. At various points, however, he appears to assert

that (1) the transfer of the PCP from the apple-juice bottle in which it was discovered to the six

glass vials entered into evidence constituted impermissible “tampering,” MTD at ECF pp. 4–5;

(2) there are “inexplicable” weight variances in the DEA records associated with the PCP,

potentially arising out of said tampering, id.; and (3) more generally, the chain of custody was

not properly “evidenced or memorialized.” Id. at ECF p. 3. We need not get mired in the weeds

to conclude that Fairnot is incorrect as a matter of law.

To begin, the existence of gaps in the chain of custody, and of resulting minor variances

in the amount of the drug, go to the weight that the factfinder might assign to the evidence, not to

its admissibility. Melendez-Diaz v. Massachusetts, 557 U.S. 305, 311 n.1 (2009); United States

v. Mitchell, 816 F.3d 865, 872 (D.C. Cir. 2016). Fairnot’s reliance on Novak v. District of

Columbia, 160 F.2d 588 (D.C. Cir. 1947), is misplaced, as the D.C. Circuit has “retreated” from

Novak’s requirement of an unbroken chain of custody. United States v. Mejia, 597 F.3d 1329,

1335 (D.C. Cir. 2010). Of course, just as he did at the first trial, Fairnot will be able to air his

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Fairnot, (D.D.C. 2026).

United States v. Fairnot (United States v. Fairnot) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Mejia
597 F.3d 1329 (D.C. Circuit, 2010)
United States v. Blue
384 U.S. 251 (Supreme Court, 1966)
Melendez-Diaz v. Massachusetts
557 U.S. 305 (Supreme Court, 2009)
United States v. John E. Jones
524 F.2d 834 (D.C. Circuit, 1975)
In Re Sealed Case
99 F.3d 1175 (D.C. Circuit, 1997)
Novak v. District of Columbia
160 F.2d 588 (D.C. Circuit, 1947)
United States v. Javier Ballestas
795 F.3d 138 (D.C. Circuit, 2015)
United States v. Sherman Mitchell
816 F.3d 865 (D.C. Circuit, 2016)
United States v. Haldeman
559 F.2d 31 (D.C. Circuit, 1976)